Datar Cancer Genetics is at the forefront of innovative cancer care, focusing on non-invasive solutions for early detection, diagnosis, and personalized treatment of cancer. The company specializes in blood-based diagnostics, utilizing advanced technologies such as liquid biopsy to identify cancer at its earliest stages. This approach allows for the analysis of Circulating Tumor Cells (CTCs) and DNA/RNA fragments, providing critical insights into tumor biology and heterogeneity. By leveraging these molecular insights, Datar Cancer Genetics aims to enhance treatment strategies and monitor disease progression or recurrence, ultimately improving patient outcomes.

In addition to early detection, Datar Cancer Genetics emphasizes the importance of personalized therapy. Recognizing that each cancer case is unique, the company offers deep genomic and cellular analyses to tailor treatment plans to individual patients. This personalized approach not only addresses the specific characteristics of a patient's cancer but also aims to overcome the challenges posed by cancer cells that can evade standard treatments. Through relentless research and collaboration, Datar Cancer Genetics is committed to advancing non-invasive technologies that can transform cancer care and improve survival rates.

India

They are building a molecular oncology facility with a fully equipped laboratory, integrated process platforms, an in-house bioinformatics team, and a huge genetic database for precise and updated reporting

Datar Cancer Genetics

Company Details